Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1860 1
1865 1
1867 1
1880 1
1883 1
1885 1
1889 2
1893 2
1895 2
1901 1
1902 1
1904 1
1905 1
1910 1
1911 1
1913 1
1915 2
1917 1
1918 1
1924 1
1925 2
1929 3
1931 2
1932 2
1933 1
1934 2
1935 1
1937 2
1938 2
1939 1
1941 3
1942 2
1944 3
1945 3
1946 13
1947 15
1948 8
1949 16
1950 13
1951 12
1952 13
1953 8
1954 12
1955 27
1956 7
1957 9
1958 8
1959 13
1960 15
1961 17
1962 13
1963 32
1964 64
1965 56
1966 21
1967 13
1968 20
1969 22
1970 17
1971 22
1972 27
1973 28
1974 20
1975 26
1976 42
1977 41
1978 33
1979 57
1980 48
1981 60
1982 51
1983 73
1984 104
1985 105
1986 77
1987 104
1988 73
1989 94
1990 96
1991 101
1992 129
1993 119
1994 101
1995 105
1996 125
1997 148
1998 117
1999 117
2000 121
2001 134
2002 145
2003 150
2004 151
2005 179
2006 207
2007 184
2008 209
2009 252
2010 257
2011 280
2012 295
2013 346
2014 344
2015 349
2016 364
2017 389
2018 408
2019 455
2020 460
2021 439
2022 418
2023 380
2024 135

Text availability

Article attribute

Article type

Publication date

Search Results

8,914 results

Results by year

Filters applied: . Clear all
Page 1
Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Adeleke M, Vickerstaff V, Ambler G, Hunter R, Bunce C, Nathwani N, Barton K; LiGHT Trial Study Group. Gazzard G, et al. Ophthalmology. 2023 Feb;130(2):139-151. doi: 10.1016/j.ophtha.2022.09.009. Epub 2022 Sep 17. Ophthalmology. 2023. PMID: 36122660 Free article. Clinical Trial.
PURPOSE: The Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial has shown selective laser trabeculoplasty (SLT) to be clinically and cost-effective as a primary treatment of open-angle glaucoma (OAG) and ocular hypertension (OHT) at 3 years. ...No …
PURPOSE: The Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial has shown selective laser trabeculoplasty (SLT) to be cli …
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C, Wormald R, Nathwani N, Barton K, Rubin G, Buszewicz M; LiGHT Trial Study Group. Gazzard G, et al. Lancet. 2019 Apr 13;393(10180):1505-1516. doi: 10.1016/S0140-6736(18)32213-X. Epub 2019 Mar 9. Lancet. 2019. PMID: 30862377 Free PMC article. Clinical Trial.
BACKGROUND: Primary open angle glaucoma and ocular hypertension are habitually treated with eye drops that lower intraocular pressure. ...INTERPRETATION: Selective laser trabeculoplasty should be offered as a first-line treatment for open angle glau …
BACKGROUND: Primary open angle glaucoma and ocular hypertension are habitually treated with eye drops that lower intraocular p …
Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Barton K, Wormald R, Morris S, Hunter R, Rubin G, Buszewicz M, Ambler G, Bunce C; LiGHT Trial Study Group. Gazzard G, et al. Br J Ophthalmol. 2018 May;102(5):593-598. doi: 10.1136/bjophthalmol-2017-310877. Epub 2017 Sep 13. Br J Ophthalmol. 2018. PMID: 28903966 Clinical Trial.
PURPOSE: The Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial aims to establish whether initial treatment with selective laser trabeculoplasty (SLT) is superior to initial treatment with topical medication for primary open-angle glaucoma …
PURPOSE: The Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial aims to establish whether initial treatment with selectiv …
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up.
Gedde SJ, Feuer WJ, Lim KS, Barton K, Goyal S, Ahmed II, Brandt JD; Primary Tube Versus Trabeculectomy Study Group. Gedde SJ, et al. Ophthalmology. 2022 Dec;129(12):1344-1356. doi: 10.1016/j.ophtha.2022.07.003. Epub 2022 Jul 12. Ophthalmology. 2022. PMID: 35835337 Free PMC article. Clinical Trial.
METHODS: Patients were enrolled at 16 clinical centers and randomly assigned to treatment with a tube shunt (350-mm(2) Baerveldt glaucoma implant) or trabeculectomy with mitomycin C (MMC) (0.4 mg/ml for 2 minutes). ...CONCLUSIONS: Trabeculectomy with M …
METHODS: Patients were enrolled at 16 clinical centers and randomly assigned to treatment with a tube shunt (350-mm(2) Baerveldt g …
Pregnancy and the eye.
Khong EWC, Chan HHL, Watson SL, Lim LL. Khong EWC, et al. Curr Opin Ophthalmol. 2021 Nov 1;32(6):527-535. doi: 10.1097/ICU.0000000000000778. Curr Opin Ophthalmol. 2021. PMID: 34605446 Review.
RECENT FINDINGS: Refractive changes are common and may persist in the postpartum in patients with keratoconus. Although new medical and surgical glaucoma treatments are available, their safety in pregnancy is unknown. Limited use of topical and systemic glaucoma …
RECENT FINDINGS: Refractive changes are common and may persist in the postpartum in patients with keratoconus. Although new medical and surg …
Laser trabeculoplasty.
Reiss GR, Wilensky JT, Higginbotham EJ. Reiss GR, et al. Surv Ophthalmol. 1991 May-Jun;35(6):407-28. doi: 10.1016/0039-6257(91)90106-p. Surv Ophthalmol. 1991. PMID: 1882321 Free article. Review.
Over a decade, laser trabeculoplasty has evolved from being a novel new treatment to one that is a commonly accepted intervention in the management of open-angle glaucoma. Despite its widespread use, however, there are still many unanswered questions about la …
Over a decade, laser trabeculoplasty has evolved from being a novel new treatment to one that is a commonly accepted intervent …
Current management of glaucoma.
Lusthaus J, Goldberg I. Lusthaus J, et al. Med J Aust. 2019 Mar;210(4):180-187. doi: 10.5694/mja2.50020. Epub 2019 Feb 14. Med J Aust. 2019. PMID: 30767238 Review.
It may be used as an initial treatment, as a substitute for eye drops, or to delay glaucoma drainage surgery. Recent advancements in glaucoma surgery have seen an influx of minimally invasive glaucoma surgery devices, which are being used more frequent …
It may be used as an initial treatment, as a substitute for eye drops, or to delay glaucoma drainage surgery. Recent advanceme …
Developments in laser trabeculoplasty.
Tsang S, Cheng J, Lee JW. Tsang S, et al. Br J Ophthalmol. 2016 Jan;100(1):94-7. doi: 10.1136/bjophthalmol-2015-307515. Epub 2015 Sep 16. Br J Ophthalmol. 2016. PMID: 26377417 Review.
Laser trabeculoplasty has an increasing important role in the management of glaucoma as more emphasis is placed on minimally invasive therapies. ...These lasers help to reduce the intraocular pressure (IOP) and the burden of glaucoma medical therapy. Literatu …
Laser trabeculoplasty has an increasing important role in the management of glaucoma as more emphasis is placed on minimally i …
Selective laser trabeculoplasty.
Latina MA, de Leon JM. Latina MA, et al. Ophthalmol Clin North Am. 2005 Sep;18(3):409-19, vi. doi: 10.1016/j.ohc.2005.05.005. Ophthalmol Clin North Am. 2005. PMID: 16054998 Review.
Selective laser trabeculoplasty (SLT) has been shown to be safe, well tolerated, and effective in intraocular pressure (IOP) reduction as therapy in several forms of open-angle glaucoma. ...SLT is also a simple technique for an ophthalmologist to learn as the large …
Selective laser trabeculoplasty (SLT) has been shown to be safe, well tolerated, and effective in intraocular pressure (IOP) reductio …
Medical therapy for glaucoma: A review.
Casson RJ. Casson RJ. Clin Exp Ophthalmol. 2022 Mar;50(2):198-212. doi: 10.1111/ceo.13989. Epub 2022 Jan 17. Clin Exp Ophthalmol. 2022. PMID: 35037367 Review.
This strategy constitutes the foundation for the medical management of glaucoma, the evolution of which, until only recently, has been in relative stagnation. ...However, while pharmacological options are expanding, the traditional role of topical medical therapy is being …
This strategy constitutes the foundation for the medical management of glaucoma, the evolution of which, until only recently, has bee …
8,914 results